At Vitro Biopharma, our goal is to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market. We are committed to translating innovative science into medicines that transform the lives of patients with various diseases. Our stem cell products and technology are based upon MSCs. We offer basic tools to support stem cell research and clinical studies of MSCs. Our products include both native MSCs and various derivatives, our MSC-Gro™ specialty cell culture media for support of growth and differentiation of MSCs. Our cell lines include native mesenchymal stem cells, Cancer-Associated Fibroblasts (CAFs) & native fibroblasts for advanced cancer research. We have developed several novel cell culture media formulations through over 30 years of stem cell research. We now offer various formulations for both stem cells and primary cell culture that feature numerous competitive advantages. These include faster growth, resulting in significantly greater cellular yield, higher quality and potency, vastly improved stability and complete formulations without the necessity of mixing prior to use.